MedPath

Determination of Protein Requirements in Pregnancy

Not Applicable
Completed
Conditions
Pregnancy
Interventions
Dietary Supplement: Protein Intake
Registration Number
NCT01784198
Lead Sponsor
University of British Columbia
Brief Summary

Protein is an essential part of our diet. It is used to build muscle and body tissue, send signals throughout our body and to support the immune system. Dietary protein is even more crucial during pregnancy as it is needed for healthy growth and development of the baby. There is very minimal data available on how much additional protein is required during pregnancy. Current recommendations are based on older techniques such as nitrogen balance studies of non-pregnant adults and minimally based on pregnancy specific data. There is no scientific information regarding the amount of protein needed during different stages of pregnancy.

The investigators hypothesize that the current recommendations of protein intake during pregnancy are underestimated.

The goal of this study is to measure protein requirement in healthy pregnant women (19-35y)using a more quick and modern technique called the indicator amino acid oxidation technique (IAAO).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
20
Inclusion Criteria

Healthy pregnant women

  • Singleton pregnancy
  • Maternal age 19-35y
  • In good health (free of chronic/acute disease,full range of physical mobility)
  • Healthy pre-pregnancy body mass index
Read More
Exclusion Criteria

Women

  • not pregnant
  • Pregnant with more than one child
  • Singleton pregnancy outside the age range of 19-35y
  • Not in good health or have a metabolic, neurological, genetic, or immune disorder, including gestational diabetes or anemia
  • smoke or consume alcohol during their pregnancy
  • classified as underweight (<18.5 kg/m2), overweight (25-30 kg/m2) or obese (>30 kg/m2)
  • allergic to eggs and egg protein
  • severe nausea/vomiting throughout their pregnancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Protein IntakeProtein IntakeDietary supplement:Protein intake
Primary Outcome Measures
NameTimeMethod
13 Carbon dioxide production8 hours (1 study day)

Urine and breath samples will be collected during the study to measure the rate of oxidation of tracer in expired breath and flux by enrichment in urine.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Child & Family Research Institute

🇨🇦

Vancouver, British Columbia, Canada

© Copyright 2025. All Rights Reserved by MedPath